Addus HomeCare (NASDAQ:ADUS) Receives “Overweight” Rating from Stephens

Stephens reaffirmed their overweight rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research note published on Wednesday, Marketbeat reports. Stephens currently has a $142.00 target price on the stock.

Several other equities analysts have also recently issued reports on ADUS. Macquarie restated an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 27th. StockNews.com cut Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Oppenheimer raised their target price on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. Finally, JMP Securities started coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price on the stock. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $132.78.

Addus HomeCare Price Performance

Shares of ADUS opened at $90.28 on Wednesday. The business’s fifty day moving average price is $115.98 and its 200 day moving average price is $123.59. Addus HomeCare has a 12-month low of $87.88 and a 12-month high of $136.72. The stock has a market capitalization of $1.64 billion, a PE ratio of 20.66, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. As a group, research analysts anticipate that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares in the company, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 4.60% of the stock is owned by insiders.

Hedge Funds Weigh In On Addus HomeCare

Hedge funds have recently modified their holdings of the company. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Addus HomeCare during the 3rd quarter valued at $1,622,000. JPMorgan Chase & Co. grew its holdings in shares of Addus HomeCare by 10.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock worth $24,371,000 after acquiring an additional 16,997 shares during the last quarter. Principal Financial Group Inc. grew its holdings in shares of Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after acquiring an additional 75,409 shares during the last quarter. Victory Capital Management Inc. grew its holdings in shares of Addus HomeCare by 6.1% in the 3rd quarter. Victory Capital Management Inc. now owns 84,960 shares of the company’s stock worth $11,302,000 after acquiring an additional 4,913 shares during the last quarter. Finally, Quest Partners LLC grew its holdings in shares of Addus HomeCare by 4,087.0% in the 3rd quarter. Quest Partners LLC now owns 11,263 shares of the company’s stock worth $1,498,000 after acquiring an additional 10,994 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.